Please sign in to follow a disease.
Danish knee questionnaire under review for accuracy
NCT ID NCT06257849
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to confirm that a Danish version of the Banff Patella Instability Instrument (BPII 2.0) is a valid and reliable tool for measuring quality of life in people with patellar dislocations. Researchers will enroll 65 Danish-speaking adults with patella instability and compare their responses on several knee-related questionnaires. The goal is to ensure the Danish version works as well as the original English one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 65 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with Patella instability
- Ages
-
14 to 40 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Danish Speaking * Patella instability problems Exclusion Criteria: * None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Patella dysplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aarhus University Hospital
Aarhus, 8200, Denmark
-
Division of Sports Trauma, Palle Juul-Jensens Boulevard 99
Aarhus N, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.